July 15, 2024 | Vensana Capital® Portfolio News

Stryker completes acquisition of Artelon, Inc.

20

Novel FDA PMA & de novo 510k approvals

55

U.S. Commercial Product Launches

39

Level I Clinical Trials

31

Strategic Financings

31

Exits by IPO or M&A